y 27632 has been researched along with lysophosphatidylcholines in 5 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Ito, Y; Kume, H; Yamaki, K | 1 |
| Ishibashi, T; Kimura, J; Maruyama, Y; Matsuoka, I; Nagata, K; Ohkawara, H; Sakamoto, T; Sakurada, S; Sugimoto, K; Yokoyama, K | 1 |
| Barth, H; Bolz, SS; Galle, J; Gambaryan, S; Görg, M; Mameghani, A; Pohl, U; Quaschning, T; Raff, U; Seibold, S; Wanner, C | 1 |
| Kim, SU; Masuda, J; McLarnon, JG; Nagai, A; Ryu, JK; Sheikh, AM | 1 |
| Ieiri, I; Iwase, M; Kitazono, T; Ohdo, S; Sonoki, K; Takata, Y | 1 |
5 other study(ies) available for y 27632 and lysophosphatidylcholines
| Article | Year |
|---|---|
Role of lysophosphatidylcholine in the desensitization of beta-adrenergic receptors by Ca(2+) sensitization in tracheal smooth muscle.
Topics: Adenylate Cyclase Toxin; Adrenergic beta-Agonists; Amides; Animals; Bucladesine; Calcium; Cholera Toxin; Colforsin; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; In Vitro Techniques; Indoles; Isoproterenol; Lysophosphatidylcholines; Male; Maleimides; Methacholine Chloride; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth; Pyridines; Receptors, Adrenergic, beta; rho GTP-Binding Proteins; Spectrometry, Fluorescence; Theophylline; Trachea; Virulence Factors, Bordetella | 2001 |
HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Topics: ADP Ribose Transferases; Amides; Aorta; Botulinum Toxins; Calcium; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Fluid; Intracellular Signaling Peptides and Proteins; Lysophosphatidylcholines; Membrane Potentials; Mevalonic Acid; Patch-Clamp Techniques; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Type C Phospholipases | 2002 |
Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA.
Topics: ADP Ribose Transferases; Amides; Angiotensin II; Animals; Aorta; Biological Transport; Cattle; Cells, Cultured; Clostridium; Drug Synergism; Felodipine; Female; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Losartan; Lysophosphatidylcholines; Male; Protein Serine-Threonine Kinases; Pyridines; Rabbits; rho-Associated Kinases; rhoA GTP-Binding Protein; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Lysophosphatidylcholine induces glial cell activation: role of rho kinase.
Topics: Amides; Animals; Brain; Cell Movement; Cells, Cultured; Cyclooxygenase 2; Enzyme Activation; Enzyme Inhibitors; Fetus; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-1beta; Lysophosphatidylcholines; Male; Neuroglia; Nitric Oxide Synthase Type II; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Small Interfering; Time Factors | 2009 |
Statin inhibits the expression of secretory phospholipase A2 and subsequent monocyte chemoattractant protein-1 in human endothelial cells.
Topics: Amides; Chemokine CCL2; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lysophosphatidylcholines; Phospholipases A2, Secretory; Polyisoprenyl Phosphates; Pyridines; Quinolines; RNA, Messenger; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2014 |